rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1996-9-10
|
pubmed:abstractText |
To describe the postoperative course of patients who underwent hyperthermic isolated limb perfusion with recombinant tumor necrosis factor (TNF)-alpha and melphalan after pretreatment with recombinant interferon-gamma as treatment for recurrent melanoma, primary nonresectable soft-tissue tumors, planocellular carcinoma, or metastatic carcinoma. To measure systemic TNF-alpha concentrations and relate these values with indices of disease severity.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0090-3493
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
765-70
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8706451-Adolescent,
pubmed-meshheading:8706451-Adult,
pubmed-meshheading:8706451-Aged,
pubmed-meshheading:8706451-Antineoplastic Agents, Alkylating,
pubmed-meshheading:8706451-Chemotherapy, Cancer, Regional Perfusion,
pubmed-meshheading:8706451-Combined Modality Therapy,
pubmed-meshheading:8706451-Extremities,
pubmed-meshheading:8706451-Female,
pubmed-meshheading:8706451-Hemodynamics,
pubmed-meshheading:8706451-Humans,
pubmed-meshheading:8706451-Hyperthermia, Induced,
pubmed-meshheading:8706451-Interferon-gamma,
pubmed-meshheading:8706451-Linear Models,
pubmed-meshheading:8706451-Male,
pubmed-meshheading:8706451-Melphalan,
pubmed-meshheading:8706451-Middle Aged,
pubmed-meshheading:8706451-Neoplasms,
pubmed-meshheading:8706451-Prospective Studies,
pubmed-meshheading:8706451-Recombinant Proteins,
pubmed-meshheading:8706451-Severity of Illness Index,
pubmed-meshheading:8706451-Systemic Inflammatory Response Syndrome,
pubmed-meshheading:8706451-Tumor Necrosis Factor-alpha
|
pubmed:year |
1996
|
pubmed:articleTitle |
High plasma tumor necrosis factor (TNF)-alpha concentrations and a sepsis-like syndrome in patients undergoing hyperthermic isolated limb perfusion with recombinant TNF-alpha, interferon-gamma, and melphalan.
|
pubmed:affiliation |
Department of Anesthesia, Royal Victoria Infirmary, Newcastle on Tyne, UK.
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|